Alzheimer’s Association (2024). Alzheimer’s Association 2024 Alzheimer’s Disease Facts and Figures.
Alzheimer’s Association. (2022). 2022 Alzheimer’s disease facts and Figures - More than normal aging: Understanding mild cognitive impairment. Alzheimer’s & Dementia.
Brickman, A. M., Manly, J. J., Honig, L. S., et al. (2021). Plasma p-tau181, p-tau217, and other blood-based alzheimer’s disease biomarkers in a multi-ethnic, community study. Alzheimer’s & Dementia, 17(8), 1353–1364. https://doi.org/10.1002/ALZ.12301
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198. https://doi.org/10.1016/0022-3956(75)90026-6
Franzen, S., Smith, J. E., van den Berg, E., Rivera Mindt, M., van Bruchem-Visser, R. L., & Abner, E. L. (2022). Diversity in alzheimer’s disease drug trials: The importance of eligibility criteria. Alzheimer’s & Dementia, 18(4), 810–823. https://doi.org/10.1002/ALZ.12433
Freitas, S., Simões, M. R., Alves, L., & Santana, I. (2013). Montreal cognitive assessment: Validation study for mild cognitive impairment and alzheimer disease. Alzheimer Disease & Associated Disorders, 27(1), 37–43. https://doi.org/10.1097/WAD.0b013e3182420bfe
Gauthier, S., Rosa-Neto, P., Morais, J., & Webster, C. (2021). World alzheimer report 2021: Journey through the diagnosis of dementia. Alzheimer’s Disease International. https://www.alzint.org/resource/world-alzheimer-report-2021
Huber, H., Ashton, N. J., Schieren, A., Montoliu-Gaya, L., Di Molfetta, G., & Brum, W. S. (2023). Levels of alzheimer’s disease blood biomarkers are altered after food intake—A pilot intervention study in healthy adults. Alzheimer’s & Dementia, 19(12), 5531–5540. https://doi.org/10.1002/ALZ.13163
Jack, C. R., Andrews, J. S., Beach, T. G., Buracchio, T., Dunn, B., Graf, A., & Sperling, R. (2024). Revised criteria for diagnosis and staging of alzheimer’s disease: Alzheimer’s association workgroup. Alzheimer’s & Dementia, 20(8), 5143–5169. https://doi.org/10.1002/ALZ.13859
Kandiah, N., Zhang, A., Bautista, D. C., Silva, E., Ting, S. K., Ng, A., & Ling, T. (2016). Early detection of dementia in multilingual populations: Visual cognitive assessment test (VCAT). Journal of Neurology Neurosurgery & Psychiatry, 87(2), 156–160. https://doi.org/10.1136/JNNP-2014-309647
Lim, L., Ng, T. P., Ong, A. P., Tan, M. P., Cenina, A. R., & Gao, Q. (2018). A novel language-neutral visual cognitive assessment test (VCAT): Validation in four Southeast Asian countries. Alzheimer’s Research & Therapy, 10(1). https://doi.org/10.1186/S13195-017-0333-Z
Luis, C. A., Keegan, A. P., & Mullan, M. (2009). Cross validation of the Montreal Cognitive Assessment in community-dwelling older adults residing in the southeastern US. International Journal of Geriatric Psychiatry, 24, 197–201. https://doi.org/10.1002/gps.2101
Mielke, M. M., Dage, J. L., Frank, R. D., Algeciras-Schimnich, A., Knopman, D. S., Lowe, V. J., & Jack, C. R. (2022). Performance of plasma phosphorylated tau 181 and 217 in the community. Nature Medicine, 28(7), 1398–1405. https://doi.org/10.1038/S41591-022-01822-2
Mitchell, A. J. (2009). A meta-analysis of the accuracy of the Mini-Mental State Examination in the detection of dementia and mild cognitive impairment. Journal of Psychiatric Research, 43(4), 411–431. https://doi.org/10.1016/J.JPSYCHIRES.2008.04.014
Morris, J. C. (1993). The clinical dementia rating (CDR): Current version and scoring rules. Neurology, 43(11), 2412–2414. https://doi.org/10.1212/WNL.43.11.2412-A
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005). The Montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53, 695–699.
Nuño, M. M., Gillen, D. L., Dosanjh, K. K., Brook, J., Elashoff, D., & Ringman, J. M. (2017). Attitudes toward clinical trials across the alzheimer’s disease spectrum. Alzheimer’s Research & Therapy, 9(1). https://doi.org/10.1186/S13195-017-0311-5
O’Driscoll, C., & Shaikh, M. (2017). Cross-cultural applicability of the Montreal Cognitive Assessment (MoCA): A systematic review. Journal of Alzheimer’s Disease, 58(3), 789–801. https://doi.org/10.3233/JAD-161042
Peavy, G. M., Jenkins, C. W., Little, E. A., Gigliotti, C., Calcetas, A., & Edland, S. D. (2020). Community memory screening as a strategy for recruiting older adults into alzheimer’s disease research. Alzheimer’s Research & Therapy, 12(1). https://doi.org/10.1186/S13195-020-00643-0
Randolph, C., Tierney, M. C., Mohr, E., & Chase, T. N. (1998). The RepeatableBattery for the Assessment of Neuropsychological Status (RBANS): Preliminary clinical validity. Journal of Clinical and Experimental Neuropsychology, 20(3), 310–319. https://doi.org/10.1076/JCEN.20.3.310.823
Roalf, D. R., Moberg, P. J., Xie, S. X., Wolk, D. A., Moelter, S. T., & Arnold, S. E. (2013). Comparative accuracies of two common screening instruments for classification of alzheimer’s disease, mild cognitive impairment, and healthy aging. Alzheimer’s & Dementia, 9(5), 529–537. https://doi.org/10.1016/j.jalz.2012.10.001
Rosen, W. G., Mohs, R. C., & Davis, K. L. (1984). A new rating scale for Alzheimer’s disease. American Journal of Psychiatry, 141(11), 1356-1364. https://doi.org/10.1176/AJP.141.11.1356
Rossetti, H. C., Lacritz, L. H., Cullum, C. M., & Weiner, M. F. (2011). Normative data for the Montreal cognitive assessment (MoCA) in a population-based sample. Neurology, 77(13), 1272–1275. https://doi.org/10.1212/WNL.0b013e318230208a
Stern, S. (2014). Psychometric properties of the Saint Louis University Mental Status Examination (SLUMS) for the identification of mild cognitive impairment (MCI) in a veteran sample (Doctoral dissertation, Georgia State University). https://doi.org/10.57709/5272343
Tariq, S. H., & Tumosa, N. (2006). Comparison of the Saint Louis University mental status examination and the Mini-Mental state examination for detecting dementia and mild neurocognitive disorder—a pilot study. The American Journal of Geriatric Psychiatry, 14, 900–910.
Thijssen, E. H., La Joie, R., Strom, A., Fonseca, C., Iaccarino, L., Wolf, A., & Rabinovici, G. D. (2021). Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer’s disease and frontotemporal lobar degeneration: A retrospective diagnostic performance study. The Lancet Neurology, 20(9), 739–752. https://doi.org/10.1016/S1474-4422(21)00214-3
World Health Organization (2023). Dementia. Retrieved September 28, 2023, from https://www.who.int/news-room/fact-sheets/detail/dementia
Comments (0)